White Paper: Fit-for-purpose Analytics for Gene Therapy Manufacturing

Are you using the right analytics for your gene therapies? The use of fit-for-purpose analytics is crucial for improving process control and ensuring that gene therapy products delivered to patients are of the highest quality and safety. Download our whitepaper to learn how to select the most appropriate analytics for your needs. 

Adeno-associated virus (AAV) vectors have demonstrated significant therapeutic potential in the production of gene therapies. However, the AAV manufacturing process often results in the production of empty, partial or overfull capsids, which lack the therapeutic benefit and are considered product-related impurities. Thus, it is crucial to control and monitor the distribution of AAV capsid content, using phase-appropriate analytical techniques. 

Read this white paper to learn: 

• The importance of analytics in AAV gene therapy manufacturing 
• An overview of analytical techniques for measuring the empty/full ratio, including their advantages and limitations 
• A case study evaluating various analytical techniques for determining empty/full ratio

Download white paper to explore how the right analytics can elevate your gene therapy manufacturing: